Exploring the Potential of CAS 98548-81-3 in Pharmaceutical R&D
The relentless pursuit of novel therapeutics in the pharmaceutical industry hinges on the availability of versatile and high-quality chemical building blocks. 4-(Dimethylamino)-2-butenoic acid hydrochloride, identified by CAS number 98548-81-3, is one such compound that has garnered significant attention for its role as a key intermediate in advanced pharmaceutical research and development.
This chemical entity, typically found as a white to off-white solid, possesses a unique molecular architecture that lends itself to the synthesis of complex organic molecules. Its primary significance lies in its application for creating tricyclic nitrogen heterocyclic compounds. These structural motifs are of immense interest to medicinal chemists, particularly in the oncology space, as they form the basis of many promising anti-cancer drug candidates. Researchers aiming to buy CAS 98548-81-3 for these innovative projects require a reliable supply chain to ensure uninterrupted research progress.
The sourcing of such specialized intermediates often leads researchers and procurement managers to consider international markets, with China being a major supplier of fine chemicals. When evaluating manufacturers and suppliers of 4-(Dimethylamino)-2-butenoic acid hydrochloride, key considerations include product purity (generally expected to be 98% or higher), consistency of batch quality, and competitive pricing. It is also prudent to request detailed product specifications and safety data sheets from potential vendors.
The price for CAS 98548-81-3 can fluctuate based on market demand, purity, and the volume purchased. However, for critical R&D endeavors, securing a consistent supply from a reputable manufacturer is paramount. Companies looking to buy this compound should engage with suppliers who demonstrate a commitment to quality control and can offer technical support. As pharmaceutical R&D continues to push boundaries, the demand for specialized intermediates like 4-(Dimethylamino)-2-butenoic acid hydrochloride is set to remain strong, underscoring the importance of strategic sourcing from dependable manufacturers.
Perspectives & Insights
Logic Thinker AI
“As pharmaceutical R&D continues to push boundaries, the demand for specialized intermediates like 4-(Dimethylamino)-2-butenoic acid hydrochloride is set to remain strong, underscoring the importance of strategic sourcing from dependable manufacturers.”
Molecule Spark 2025
“The relentless pursuit of novel therapeutics in the pharmaceutical industry hinges on the availability of versatile and high-quality chemical building blocks.”
Alpha Pioneer 01
“4-(Dimethylamino)-2-butenoic acid hydrochloride, identified by CAS number 98548-81-3, is one such compound that has garnered significant attention for its role as a key intermediate in advanced pharmaceutical research and development.”